BioCryst to Present at Upcoming Investor Conferences

Rhea-AI Summary

BioCryst Pharmaceuticals (Nasdaq: BCRX) announced its participation in two upcoming healthcare conferences. The company will present at the Cowen 43rd Annual Health Care Conference in Boston, MA, on March 8, 2023, at 12:50 p.m. ET, and at the Barclays 2023 Global Healthcare Conference in Miami, FL, on March 14, 2023, at 9:30 a.m. ET. Investors can access live webcasts and replays via the Investors & Media section of BioCryst's website. The company focuses on developing innovative oral medicines for rare diseases with high unmet medical needs.

RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the Cowen 43^rd Annual Health Care Conference in Boston, MA on Wednesday, March 8^th at 12:50 p.m. ET and the Barclays 2023 Global Healthcare Conference in Miami, FL on Tuesday, March 14^th at 9:30 a.m. ET.

Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO^® (berotralstat) is approved in the United States and many global markets. BioCryst has active programs to develop oral medicines for multiple targets across the complement system, including BCX10013, an oral Factor D inhibitor in clinical development. RAPIVAB^® (peramivir injection) is approved in the U.S. and multiple global markets, with post-marketing commitments ongoing. For more information, please visit the company’s website at www.biocryst.com.

BCRXW

Investor Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com

Media Contact:
Catherine Collier Kyroulis
+1 917 886 5586
ckyroulis@biocryst.com

FAQ

When will BioCryst Pharmaceuticals present at the Cowen 43rd Annual Health Care Conference?

BioCryst Pharmaceuticals will present at the Cowen 43rd Annual Health Care Conference on March 8, 2023, at 12:50 p.m. ET.

What is the date of BioCryst Pharmaceuticals' presentation at the Barclays 2023 Global Healthcare Conference?

BioCryst Pharmaceuticals will present at the Barclays 2023 Global Healthcare Conference on March 14, 2023, at 9:30 a.m. ET.

How can I access the live audio webcasts of BioCryst Pharmaceuticals' presentations?

Live audio webcasts of BioCryst Pharmaceuticals' presentations can be accessed in the Investors & Media section of their website.

What type of medicines does BioCryst Pharmaceuticals develop?

BioCryst Pharmaceuticals develops novel, oral, small-molecule medicines aimed at treating rare diseases with significant unmet medical needs.

What is the stock symbol for BioCryst Pharmaceuticals?

The stock symbol for BioCryst Pharmaceuticals is BCRX.